HotStockMarket.com Comments On Recent Trading Activity: ZROS, DNDN

Recent trading activity in ZROS and DNDN has drawn the attention of many traders

HotStockMarket.com has seen significant moves in the month of March for the following stocks:

Zeros & Ones (ZROS:OTC) has announced a name change to Voyant, the new symbol will be VYNT. Recent trading in ZROS has seen the stock go from $0.20 to $1.93 year to date.

Dendreon Corp (DNDN:NASDAQ) was halted at $5.22 pending a FDA announcement regarding their prostate drug. Results of "substantial evidence of efficacy and safety of PROVENGE (sipuleucel-T) for the treatment of patients with asymptomatic, metastatic, androgen-independent prostate cancer" was enough to make the stock spike to $18.05 on March 30th.

About HotStockMarket

HotStockMarket.com is the largest forum for penny stocks and a fast growing online investor community that focuses on quality discussion and research of stocks. Membership and access is free through www.hotstockmarket.com.

###


Contact Details

Company Name: Hotstockmarket.com
Issued By: Terry Jones
Address:
Website: Visit the website

by Terry Jones (few years ago!)

Latest Press Releases

The Mad Hatter Now Offer a Full Line of Hearth Products and Full Line of Grills

Diabetes Insulin Delivery Pens Market Research Report 2018

Dr Kapadia Provides Tips to Patients Interested in Hair Transplant Procedures

love vashikaran specialist

Solar Blanket Sales Market Report 2018

Spring Bottled Water Market Insights, Forecast to 2025

Biochemical Incubator Sales Market Report 2018

Quinine Sulphate Sales Market Report 2018

Automotive Chassisc System Market Insights, Forecast to 2025

2,6-Dicarboxypyridine market size in key regions like North America, Europe, Asia Pacific an..

Remove this press release ?

Due to extra work required to remove the press-releases we have started charging $1.99 for press release removal.

Your press release will be removed in 24 hours, once the payment has been received.

Search Press Release
e.g. Business, Computer, etc.